This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics

SAVINGS DEADLINE EXPIRES IN:

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
May 14-17, 2024 | In-Person + Digital
Boston, MA, USAHynes Convention Center

Jacob Hyllested-Winge, M.D.
Project Vice President, Boston Global Development at Novo Nordisk
Speaker

Profile

Jacob Hyllested-Winge, MD is a Project Vice President in Novo Nordisk, working out of Boston. He has held numerous positions across Novo Nordisk including Affairs and operations roles in Denmark and Japan, before relocating to Boston to lead nedosiran development.

Agenda Sessions

  • Development and Approval of RIVFLOZA® (Nedosiran)

    1:45pm